연구성과로 돌아가기
2023 연구성과별 연구자 정보 (429 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia | Moon, Joon Ho | Moon, JH | 12 | Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Daegu, South Korea | f0115@jnu.ac.kr; | |||||
| Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia | Sohn, Sang Kyun | Sohn, SK | 13 | Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Daegu, South Korea | f0115@jnu.ac.kr; | |||||
| Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia | Won, Jong -Ho | Won, JH | 14 | Soon Chun Hyang Univ Hosp, Dept Hematol Oncol, Seoul, South Korea | AAM-8322-2021 | Won, Jongho | f0115@jnu.ac.kr; | |||
| Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia | Kim, Sung-Hyun | Kim, SH | 15 | Dong A Univ, Dept Hematol Oncol, Coll Med, Busan, South Korea | HJA-3755-2022 | Park, Jung Hyun | f0115@jnu.ac.kr; | |||
| Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia | Kim, Hyeoung-Joon | Kim, HJ | 16 | Chonnam Natl Univ, Genom Res Ctr Hematopoiet Dis, Hwasun Hosp, Hwasun, South Korea | IAP-6721-2023 | Kim, Chang Gon | f0115@jnu.ac.kr; | |||
| Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia | Ahn, Jae-Sook | Ahn, JS | 17 | 교신저자 | Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, South Korea | f0115@jnu.ac.kr; | ||||
| Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia | Ahn, Jae-Sook | Ahn, JS | 17 | 교신저자 | Chonnam Natl Univ, Genom Res Ctr Hematopoiet Dis, Hwasun Hosp, Hwasun, South Korea | f0115@jnu.ac.kr; | ||||
| Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia | Kim, Dennis Dong Hwan | Kim, DDH | 18 | Univ Toronto, Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada | AAH-8499-2019 | Kim, Dennis | f0115@jnu.ac.kr; | |||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Lee, Beomki | Lee, B | 1 | Sungkyunkwan Univ, Samsung Med Ctr, Dept Lab Med & Genet, Sch Med, 81 Irwon Ro, Seoul 06531, South Korea | 0000-0003-3463-2121 | Lee, Beomki | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Lee, Beomki | Lee, B | 1 | Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Daejeon, South Korea | 0000-0003-3463-2121 | Lee, Beomki | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Ko, Jae-Hoon | Ko, JH | 2 | Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Infect Dis,Dept Med, 81 Irwon Ro, Seoul 06351, South Korea | 0000-0002-9490-6609 | Ko, Jae-Hoon | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Kim, Yong Chan | Kim, YC | 3 | Yonsei Univ, Coll Med, Yongin Severance Hosp, Div Infect Dis,Dept Internal Med, Yongin, South Korea | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Baek, Jin Yang | Baek, JY | 4 | Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Infect Dis,Dept Med, 81 Irwon Ro, Seoul 06351, South Korea | JXO-3331-2024 | Baek, Jin Yang | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Baek, Jin Yang | Baek, JY | 4 | Asia Pacific Fdn Infect Dis APFID, Seoul, South Korea | JXO-3331-2024 | Baek, Jin Yang | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Park, Yoon Soo | Park, YS | 5 | Yonsei Univ, Coll Med, Yongin Severance Hosp, Div Infect Dis,Dept Internal Med, Yongin, South Korea | C-6472-2015 | Park, Yoon | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; |
페이지 이동: